Opdivo (nivolumab) is indicated for the treatment of unresectable or metastatic melanoma in...
- FDA accelerated review denial is a blow to Spectrum’s poziotinib
- New drugs and therapeutic options help the immune system fight cancer
- Roche’s Tecentriq threatens BMS’ Opdivo in small cell lung cancer market
- The challenges of using stem cells in neurology
- Another BACE inhibitor fails in phase III trials
New trial announced to assess cannabidiol in Parkinson’s patients
A new Phase II clinical trial will be conducted to assess cannabidiol (CBD) for the treatment of hallucinations and delusions associated with Parkinson’s disease.
US FDA awards 12 new clinical trial research grants
The US Food and Drug Administration (FDA) has awarded 12 new clinical trial research grants to principal investigators from academia and industry across the country.
Lunch and Learn Series to Begin on 7 October
Our Lunch and Learn series is starting today and we will be hosting StemBioSys, Inc for a series of free seminars on CELLvo™ technology ‘the next evolution in Cell Culture’.
Australia offers funding support for five clinical trials
The Government of Australia has announced an $8m investment to support clinical trials across various conditions, including heart and brain diseases.
Wistar secures funds for clinical studies on opioid use in HIV patients
The Wistar Institute in the US has received more than $12m in funding from the National Institute on Drug Abuse (NIDA) to support a clinical research consortium focused on opioid use in HIV patients.
NIMH funds clinical research to improve Schizophrenia treatment
The National Institutes of Mental Health (NIMH) has granted $7.3m to researchers at the Feinstein Institutes for Medical Research to support their efforts to provide improved treatment for schizophrenia.
TrialSpark and Pfizer partner to accelerate clinical trials
Pfizer will extend its clinical trials to community doctors who have not previously been involved in any study investigations after the company signed a multi-year collaboration with TrialSpark.
SU2C to support clinical trials in breast and prostate cancers
Charity organisation Stand Up To Cancer (SU2C) has launched two research teams to support clinical trials involving patients with breast or prostate cancer.
Accenture and Bayer to implement INTIENT Clinical platform
Accenture will partner with Bayer to implement the Accenture INTIENT Clinical platform for research, clinical development, pharmacovigilance and patient services.